Savara (SVRA) Return on Capital Employed Growth (5y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Savara | 1.30 Bn | 1.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,052.00 |
| Dec 31, 2025 | -1,819.00 |
| Sep 30, 2025 | -2,465.00 |
| Jun 30, 2025 | -956.00 |
| Mar 31, 2025 | 1,072.00 |
| Dec 31, 2024 | 1,308.00 |
| Sep 30, 2024 | -602.00 |
| Jun 30, 2024 | -1,503.00 |
| Mar 31, 2024 | -853.00 |
| Dec 31, 2023 | 1,237.00 |
| Sep 30, 2023 | 1,524.00 |
| Jun 30, 2023 | 1,311.00 |
| Mar 31, 2023 | 816.00 |
| Dec 31, 2022 | -568.00 |
| Sep 30, 2022 | -499.00 |
| Jun 30, 2022 | 1,057.00 |
| Mar 31, 2022 | 6,948.00 |
| Dec 31, 2021 | 1,044.00 |
| Sep 30, 2021 | 4,804.00 |
| Jun 30, 2021 | 7,585.00 |
| Mar 31, 2021 | 7,656.00 |
| Dec 31, 2020 | 5,873.00 |
| Sep 30, 2020 | 1,465.00 |
| Jun 30, 2020 | 914.00 |
| Mar 31, 2020 | -1,254.00 |
| Dec 31, 2019 | -863.00 |
| Sep 30, 2019 | 1,023.00 |
| Jun 30, 2019 | 138.00 |
| Mar 31, 2019 | 731.00 |
| Dec 31, 2018 | -689.00 |
| Sep 30, 2018 | -1,841.00 |
| Jun 30, 2018 | -1,591.00 |
| Mar 31, 2018 | -16.00 |
| Dec 31, 2017 | 1,099.00 |
| Sep 30, 2017 | 674.00 |
| Jun 30, 2017 | -771.00 |
| Mar 31, 2017 | -6,946.00 |
| Dec 31, 2016 | -927.00 |
| Sep 30, 2016 | -4,283.00 |